Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Each year more than 23,000 people in the United States are diagnosed with brain cancer
Drug prevents mental decline associated with radiation therapy in mice.
“With all the challenges Kevin faced, he was reminded by our mother what a gift life is.”
This minimally invasive approach may reduce the burden on children with diffuse midline glioma.
Mayo Clinic study finds sparing the hippocampus leads to better outcomes.
Experts say the findings do not have clear implications for humans.
Studies have “given us the confidence” that the current safety limits remain acceptable.
Mutation revelation is a boon in an era of targeted therapies, say oncologists at UCSF, Children’s National Health System.
Financial toxicity is also about the systemic designs of our assistance programs, which are not equipped to meet the needs of the very ill.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
New target identified in glioblastoma could be effective against a common immortality mechanism in one third of cancers.
We are a community; how might we all learn together from our shared yet unique experiences?
Clinical trial tests personalized treatments in push to improve pediatric cancer survival.
Opdivo plus Yervoy delays disease progression in people with melanoma brain metastases.
The Republican lawmaker was diagnosed with glioblastoma, an aggressive brain cancer, last year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.